SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549

                                    Form 10-Q



       [X] Quarterly  report  pursuant  to  Section  13  or  15(d)  of the
           Securities Exchange Act of 1934  for the quarterly period ended
           June 30, 1996 or

       [ ] Transition report  pursuant  to  Section  13  or  15(d)  of the
           Securities Exchange Act of 1934



       Commission file number: 0-12024
                               -------

                          MAXICARE HEALTH PLANS, INC.
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)


                 Delaware                                 95-3615709
       -------------------------------               -------------------
       (State or other jurisdiction of               (I.R.S. Employer 
       incorporation or organization)                Identification No.)


       1149 South Broadway Street, Los Angeles, California       90015
       ---------------------------------------------------    ----------
       (Address of principal executive offices)               (Zip Code)


       Registrant's telephone number, including area code (213) 765-2000
                                                          --------------


            Indicate  by  check  mark whether the registrant (1) has filed
       all reports required to  be  filed  by  Section  13 or 15(d) of the
       Securities Exchange Act of 1934  during the preceding 12 months (or
       for such shorter period  that  the  registrant was required to file
       such reports), and (2) has been subject to such filing requirements
       for the past 90 days.


                         Yes   [ X ]   No   [   ]


            Indicate  by  check  mark whether the registrant has filed all
       documents and reports required to  be  filed by Sections 12, 13, or
       15(d) of the  Securities  Exchange  Act  of  1934 subsequent to the
       distribution of securities under a plan confirmed by a court.


                         Yes   [ X ]   No   [   ]

                       Exhibit Index Page 15 of 119
                               Page 1 of 119
       
       Common Stock, $.01 par value  - 17,539,318 shares outstanding as of
       August 9, 1996, of which 622,358 shares were held by the Registrant
       as disbursing agent for  the  benefit  of holders of allowed claims
       and interests under the Registrant's Joint Plan of Reorganization.




















































                                      2

       
       PART I: FINANCIAL INFORMATION
               ---------------------
       Item 1: Financial Statements
               --------------------

                 MAXICARE HEALTH PLANS, INC. AND SUBSIDIARIES
                          CONSOLIDATED BALANCE SHEETS
                    (Amounts in thousands except par value)
       
       

                                                                     June 30,    December 31,
                                                                       1996         1995
                                                                    -----------  ---------
       CURRENT ASSETS                                               (Unaudited)
                                                                          
         Cash and cash equivalents................................. $  27,932    $  49,170
         Marketable securities.....................................    63,298       49,659
         Accounts receivable, net..................................    32,655       32,946
         Deferred tax asset........................................    14,252       14,000
         Prepaid expenses..........................................     2,759        1,195
         Other current assets......................................       319          294
                                                                    ---------    ---------
           TOTAL CURRENT ASSETS....................................   141,215      147,264
                                                                    ---------    ---------
       PROPERTY AND EQUIPMENT
         Leasehold improvements....................................     5,441        5,441
         Furniture and equipment...................................    18,855       18,849
                                                                    ---------    ---------
                                                                       24,296       24,290
           Less accumulated depreciation and amortization..........    22,346       21,755
                                                                    ---------    ---------
           NET PROPERTY AND EQUIPMENT..............................     1,950        2,535
                                                                    ---------    ---------
       LONG-TERM ASSETS
         Long-term receivables.....................................       156          200
         Statutory deposits........................................    13,481       12,593
         Intangible assets, net....................................       315          244
                                                                    ---------    ---------
           TOTAL LONG-TERM ASSETS..................................    13,952       13,037
                                                                    ---------    ---------

           TOTAL ASSETS............................................ $ 157,117    $ 162,836
                                                                    =========    =========
       CURRENT LIABILITIES
         Estimated claims and incentives payable...................    37,212    $  46,232
         Accounts payable..........................................       456          689
         Deferred income...........................................     1,717        5,272
         Accrued salary expense....................................     3,336        3,296
         Payable to disbursing agent...............................     6,248        6,248
         Other current liabilities.................................     4,829        5,239
                                                                    ---------    ---------
           TOTAL CURRENT LIABILITIES...............................    53,798       66,976

       LONG-TERM LIABILITIES.......................................       807        1,155
                                                                    ---------    ---------
           TOTAL LIABILITIES.......................................    54,605       68,131
                                                                    ---------    ---------

       SHAREHOLDERS' EQUITY 
         Common stock, $.01 par value - 40,000 shares authorized,
           1996 - 17,539 shares and 1995 - 17,420 shares issued
           and outstanding.........................................       175          174
         Additional paid-in capital................................   249,237      247,690
         Accumulated deficit.......................................  (146,900)    (153,159)
                                                                    ---------    ---------
           TOTAL SHAREHOLDERS' EQUITY..............................   102,512       94,705
                                                                    ---------    ---------
           TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY.............. $ 157,117    $ 162,836
                                                                    =========    =========

                             See notes to consolidated financial statements.

       
                                      3
       
        
                                   MAXICARE HEALTH PLANS, INC. AND SUBSIDIARIES
                                       CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Amounts in thousands except per share data)
                                                    (Unaudited)

       
       


                                                                                For the three        For the six 
                                                                                months ended         months ended
                                                                                  June 30,             June 30,
                                                                             ------------------   ------------------
                                                                               1996      1995       1996      1995  
                                                                             --------  --------   --------  --------
                                                                                               
       OPERATING REVENUES................................................... $134,573  $113,692   $266,339  $226,047
                                                                             --------  --------   --------  --------
       OPERATING EXPENSES
          Physician services................................................   53,576    44,904    106,157    89,126
          Hospital services.................................................   46,487    34,594     88,456    68,195
          Outpatient services...............................................   20,348    16,197     38,534    32,122
          Other health care services........................................    3,009     2,875      6,063     6,326
                                                                             --------  --------   --------  --------
            TOTAL HEALTH CARE EXPENSES......................................  123,420    98,570    239,210   195,769

          Marketing, general and administrative expenses....................   11,817    10,591     23,263    21,165
          Depreciation and amortization.....................................      329       301        675       595
                                                                             --------  --------   --------  --------
            TOTAL OPERATING EXPENSES........................................  135,566   109,462    263,148   217,529
                                                                             --------  --------   --------  --------
       INCOME (LOSS) FROM OPERATIONS........................................     (993)    4,230      3,191     8,518

          Investment income, net of interest expense........................    1,516     1,679      3,068     3,020
                                                                             --------  --------   --------  --------
       INCOME BEFORE INCOME TAXES...........................................      523     5,909      6,259    11,538

       INCOME TAX PROVISION.................................................              1,012                1,953
                                                                             --------  --------   --------  --------
       NET INCOME........................................................... $    523  $  4,897   $  6,259  $  9,585
                                                                             ========  ========   ========  ========

       NET INCOME PER COMMON AND COMMON EQUIVALENT SHARE:

       Primary
          Primary Earnings per Common Share................................. $    .03  $    .27   $    .34  $    .61
                                                                             ========  ========   ========  ========
          Weighted average number of common and common 
            equivalent shares outstanding...................................   18,406    18,092     18,446    15,758
                                                                             ========  ========   ========  ========
       Fully Diluted
          Fully Diluted Earnings per Common Share........................... $    .03  $    .27   $    .34  $    .53
                                                                             ========  ========   ========  ========
          Weighted average number of common and common
            equivalent shares outstanding...................................   18,406    18,092     18,446    18,076
                                                                             ========  ========   ========  ========







                                           See notes to consolidated financial statements.

       


                                      4
       
        
                MAXICARE HEALTH PLANS, INC. AND SUBSIDIARIES
                    CONSOLIDATED STATEMENTS OF CASH FLOWS
                           (Amounts in thousands)
                                 (Unaudited)
       
       


            
                                                                      For the six months ended June 30,
                                                                           1996           1995  
                                                                         ---------      --------
                                                                                  
       CASH FLOWS FROM OPERATING ACTIVITIES:
       Net income....................................................... $  6,259       $  9,585
       Adjustments to reconcile net income to net cash used for
         operating activities:
         Depreciation and amortization..................................      675            595
         Benefit from deferred taxes....................................     (252)
         Amortization of restricted stock...............................      349            233
         Changes in assets and liabilities:
           (Increase) decrease in accounts receivable...................      291         (3,223)
           Decrease in estimated claims and incentives payable..........   (9,020)       (10,531)
           Increase (decrease) in deferred income.......................   (3,555)         2,148
           Changes in other miscellaneous assets and liabilities........   (2,388)           845
                                                                         --------       --------
       Net cash used for operating activities...........................   (7,641)          (348)
                                                                         --------       --------
       CASH FLOWS FROM INVESTING ACTIVITIES:
         Dispositions of property and equipment.........................                       4
         Purchases of property and equipment............................      (41)          (173)
         Increase in statutory deposits.................................     (888)          (726)
         Proceeds from sales and maturities of marketable securities....   21,131         34,578
         Purchases of marketable securities.............................  (34,770)       (34,250)
         Decrease in long-term receivables..............................       44             39
                                                                         --------       --------
       Net cash used for investing activities...........................  (14,524)          (528)
                                                                         --------       --------
       CASH FLOWS FROM FINANCING ACTIVITIES:
         Payments on capital lease obligations..........................     (272)           (80)
         Stock options exercised........................................    1,199            845
         Redemption of preferred stock..................................                    (525)
                                                                         --------       --------
       Net cash provided by financing activities........................      927            240
                                                                         --------       --------
       Net decrease in cash and cash equivalents........................  (21,238)          (636)
       Cash and cash equivalents at beginning of period.................   49,170         37,858
                                                                         --------       --------
       Cash and cash equivalents at end of period....................... $ 27,932       $ 37,222
                                                                         ========       ========
       Supplemental disclosures of cash flow information:
         Cash paid during the period for -
           Interest..................................................... $     65       $     21
           Income taxes................................................. $    263       $  1,670

       Supplemental schedule of non-cash financing activities:
           Reclassification of preferred capital accounts to 
             common stock capital accounts pursuant to the 
             conversion of preferred stock to common stock..............                $ 53,195
           Issuance of restricted common stock..........................                $  2,096





                           See notes to consolidated financial statements.

       
                                      5
       
                 MAXICARE HEALTH PLANS, INC. AND SUBSIDIARIES
                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS



       NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES: 

       Basis of Presentation
       ---------------------

       Maxicare Health Plans, Inc., a Delaware corporation ("MHP"), is a
       holding company which owns various subsidiaries, primarily health
       maintenance organizations ("HMOs").    The accompanying unaudited
       consolidated  financial   statements   have   been   prepared  in
       accordance  with  generally  accepted  accounting  principles for
       interim financial information.  In the opinion of management, all
       adjustments considered necessary  for  a fair presentation, which
       consist  solely  of  normal   recurring  adjustments,  have  been
       included.      All   significant   inter-company   balances   and
       transactions have been eliminated.  

       For further information on MHP and subsidiaries (collectively the
       "Company") refer  to  the  consolidated  financial statements and
       accompanying footnotes included in the Company's annual report on
       Form 10-K as filed  with  the  Securities and Exchange Commission
       for the year ended December 31, 1995.

       Capital Stock and Net Income Per Common and Common Equivalent
       -------------------------------------------------------------
       Share
       -----

       The Company concluded the  redemption  of its Series A Cumulative
       Convertible Preferred Stock ("Series A  Stock") on March 14, 1995
       (the "Redemption Date").   Holders  of approximately 2.27 million
       shares  of   Series   A   Stock   converted   their  shares  into
       approximately 6.25 million shares  of the Company's Common Stock.
       As a result of the redemption  of  the Series A Stock the Company
       paid no preferred stock  dividends  in 1995, and, accordingly, no
       consideration  is  given  to  preferred  stock  dividends  in the
       calculation of earnings per  share  for  the  three and six month
       periods ended June 30, 1995.

       Primary earnings per share are computed by dividing net income by
       the weighted average number  of  common shares outstanding, after
       giving effect to stock options  with  an exercise price less than
       the average market price  for  the  period.  Common shares issued
       upon the conversion of preferred  stock have been included in the
       weighted average number  of  common shares outstanding subsequent
       to the conversion date.  

       Fully diluted earnings  per  share  are  computed by dividing net
       income  by  the   weighted   average   number  of  common  shares
       outstanding, after giving effect to stock options with an 

                                      6
       
       exercise price less  than  the  market  price  at  the end of the
       period (or average market price  if  use of that price results in
       greater dilution) and shares assumed to be issued upon conversion
       of the Company's preferred stock.   Common shares issued upon the
       conversion of preferred stock have  been included in the weighted
       average number of  common  shares  outstanding  and the preferred
       shares have been  excluded  from  the  weighted average number of
       common equivalent shares outstanding subsequent to the conversion
       date. 















































                                      7
       

       Item 2:  Management's Discussion and Analysis of Financial
                -------------------------------------------------
                Condition and Results of Operations
                -----------------------------------

       Results of Operations

       Maxicare  Health  Plans,  Inc.  and  subsidiaries  (the "Company")
       reported net income of $.5 million for the three months ended June
       30, 1996, compared to $4.9 million for the same three month period
       in 1995.  Net income per common share on a fully diluted basis was
       $.03 for the second quarter of 1996, compared to $.27 for 1995. 

       For the three months  ended  June  30,  1996, the Company reported
       operating revenues of $134.6 million,  an increase of 18% or $20.9
       million when compared  to  the  same  period  in  1995.  Operating
       revenues increased as a result of  a 25% increase in the Company's
       membership over the prior year period.  A majority of the increase
       resulted from a doubling  of  membership in the Company's Medicaid
       and  Medicare  lines   of   business   primarily  in  Indiana  and
       California.  The remaining  increase  resulted from a 15% increase
       in commercial  membership  primarily  in  California  and Indiana,
       offset in part by a decrease  in  the average per member per month
       ("PMPM") commercial premium.

       The increase in operating revenues  for the second quarter of 1996
       was more than offset by  a  $24.8  million increase in health care
       expenses.  This increase  in  health  care  expenses was in part a
       result of a  $5.0  million  charge  for  unanticipated health care
       claims costs  primarily  related  to  the  Illinois  and Carolinas
       health plans, where the  Company  assumes  greater risk for claims
       costs as  compared  to  its  other  health  plans.   The remaining
       increase principally results from growth in the Company's Medicaid
       and Medicare  lines  of  business,  both  of  which  have a higher
       medical loss  ratio  (health  care  expenses  as  a  percentage of
       operating  revenues)  than   the   Company's  commercial  line  of
       business.

       Marketing, general and  administrative  ("MG&A")  expenses for the
       second quarter of 1996 increased  $1.2 million to $11.8 million as
       compared to the second quarter of 1995.  However, MG&A expenses as
       a percentage of operating revenues decreased to 8.8% for the three
       months ended June 30,  1996  as  compared  to  9.3% for the second
       quarter of 1995 primarily  as  a  result  of revenue growth in the
       Company's Medicaid line of business.

       Net investment income for the  second quarter of 1996 decreased by
       $200,000 to  $1.5  million,  as  compared  to  1995,  due to lower
       interest rates partially  offset  by  greater  cash and investment
       balances.

       The Company reported a $32,000  provision for income taxes for the
       three months ended  June  30,  1996  and  an offsetting income tax
       benefit of $32,000 due to  the Company increasing its deferred tax
       asset.  The Company reported  a  $1.0 million provision for income
       taxes for the three months ended June 30, 1995.

                                      8
       
       Operating revenues for  the  first  six  months  of 1996 increased
       17.8% to $266.3 million from $226.0 million for the same period in
       1995 primarily due to a  24%  membership increase in the Company's
       Medicaid, Medicare and  commercial  lines  of  business; offset in
       part by a 5.2% decline in  the average premium PMPM primarily as a
       result of the growth in  the  lower  premium PMPM Medicaid line of
       business.  Total health care  expenses increased $43.4 million for
       the first six months of  1996  as  compared  to the same period in
       1995 as a  result  of  the  increase  in  membership  and the $5.0
       million charge recorded  in  the  second  quarter  of  1996.  MG&A
       expenses increased $2.1 million for  the six months ended June 30,
       1996, but decreased as a  percentage of operating revenues to 8.7%
       from 9.4%.  The Company  reported  net  income of $6.3 million for
       the six months ended June 30, 1996 as compared to $9.6 million for
       the same period in 1995. 









































                                      9
       

       Liquidity and Capital Resources

       Certain of  MHP's  operating  subsidiaries  are  subject  to state
       regulations  which  require   compliance  with  certain  statutory
       deposit,   reserve,   dividend    distribution   and   net   worth
       requirements.   To  the  extent  the  operating  subsidiaries must
       comply with these  regulations,  they  may  not have the financial
       flexibility to transfer funds  to  MHP.  MHP's proportionate share
       of net assets  (after  inter-company  eliminations) which, at June
       30, 1996, may not  be  transferred  to  MHP by subsidiaries in the
       form of loans, advances or cash dividends without the consent of a
       third party is  referred  to  as  "Restricted  Net Assets".  Total
       Restricted Net Assets of  these  operating subsidiaries were $38.8
       million  at  June   30,   1996,   with  deposit  requirements  and
       limitations imposed by  state  regulations  on the distribution of
       dividends representing  $12.9  million  and  $18.6  million of the
       Restricted Net Assets, respectively, and net worth requirements in
       excess   of   deposit   requirements   and   dividend  limitations
       representing the  remaining  $7.3  million.    The Company's total
       Restricted Net Assets at  June  30,  1996  were $39.1 million.  In
       addition to  the  $23.9  million  in  cash,  cash  equivalents and
       marketable securities  held  by  MHP,  approximately $13.3 million
       could be considered available  to  transfer  to MHP from operating
       subsidiaries.

       All of MHP's operational  subsidiaries  are direct subsidiaries of
       MHP.   All  of  the  Company's  HMOs  are  federally qualified and
       licensed in the  states  where  they  operate.   Subsequent to the
       close of the Company's  fiscal  1996  second quarter, in July 1996
       the North Carolina Department of  Insurance and the South Carolina
       Department of Insurance  approved  the  expansion of the Company's
       North Carolina HMO into  the  state  of South Carolina through its
       acquisition of the existing  membership,  contracts and net assets
       of the  Company's  South  Carolina  HMO.    As  a  result  of this
       approval, the Company's North Carolina  HMO is licensed to conduct
       business in both the states  of North Carolina and South Carolina.
       Prior to such  approval,  the  operations  of  the Company's South
       Carolina HMO were under Bankruptcy Court jurisdiction.

       The operating HMOs currently pay  monthly  fees to MHP pursuant to
       administrative  services   agreements   for   various  management,
       financial, legal, computer  and  telecommunications services.  The
       Company believes that  for  the  foreseeable  future  it will have
       sufficient resources  to  fund  ongoing  operations  and remain in
       compliance with statutory financial requirements.

       With a current  ratio  (i.e.,  current  assets  divided by current
       liabilities)  of  2.6  and  less  than  $.9  million  of long-term
       liabilities at June 30, 1996, the Company does not believe that it
       needs additional  working  capital  at  this  time.   Although the
       Company believes that it would be able to raise additional working
       capital through either an equity  infusion  or borrowings if it so
       desired, the Company can not state with any degree of certainty at
       this time whether  additional  equity  capital  or working capital
       would be available to the  Company,  and if available, would be at
       terms and conditions acceptable to the Company.

                                     10
       

       PART II: OTHER INFORMATION 
                -----------------
       Item 1:  Legal Proceedings
                -----------------



       The information contained in "Part I, Item 3. Legal Proceedings" of
       the  Company's  1995  Annual   Report   on   Form  10-K  is  hereby
       incorporated by reference and the following information updates the
       information contained in the relevant subparts thereof.

       a.  PENN HEALTH

       During the period March 1, 1986  through June 30, 1989, Penn Health
       Corporation  ("Penn  Health"),   a   subsidiary   of  the  Company,
       contracted with  the  Commonwealth  of  Pennsylvania  Department of
       Public Welfare (the  "DPW")  to  provide  a  full  range of managed
       health care services to  Medicaid  enrollees under the Pennsylvania
       Medical Assistance Program  known  as  the  HealthPass Program.  On
       February 27, 1991, the  Company  filed  a  petition against the DPW
       with the Pennsylvania Board of  Claims (the "Claims Board") seeking
       in excess of $24 million in damages  for monies due from the DPW in
       connection with the HealthPass  Program  plus accrued interest (the
       "Board Action").  The  Claims  Board  consolidated the Board Action
       for purposes of  trial  with  two  separate  actions  filed by Penn
       Health hospital providers (the "Hospital Providers") and by a class
       consisting of Penn  Health  primary  care  physician providers (the
       "PCP Class") against DPW  to  secure  payment directly from the DPW
       for pre-petition services rendered  to HealthPass members. Pursuant
       to an order of the Claims Board,  the actions were set for trial in
       two phases; a liability phase and a damages phase.

       Following trial before the Claims Board in July 1994 of contractual
       issues pertaining to  DPW's  liability  the  Claims Board issued an
       order on December 2, 1994 on  the liability phase which found that:
       (i) a contract exists between Penn Health and the DPW; (ii) the DPW
       breached the contract;  and  (iii)  Penn  Health  is an independent
       general contractor and not  an  agent  of  the  DPW.   Trial on the
       parties' respective damages claims  concluded on November 30, 1995.
       All post trial  briefing  has  been  completed  and the parties are
       waiting for the Claims  Board  to  issue  its ruling on the damages
       phase and to enter a  judgment  in  the  Board Action.  The Company
       believes that its damage  claims  are  meritorious and that it will
       prevail in the Board Action.

       On  June  7  and  19,  1996  the  Company  and  Penn  Health  filed
       complaints with the United States  Bankruptcy Court for the Central
       District  of  California  (the   "Bankruptcy  Court")  against  the
       Hospital Providers, and the PCP Class and its counsel, respectively
       (the "Provider Bankruptcy Actions"), for violating the terms of the
       Company's and  Penn  Health's  Joint  Plan  of  Reorganization (the
       "Plan") and the Bankruptcy Court's  order  confirming the Plan.  In
       the Provider Bankruptcy Actions  the  Company and Penn Health seek,
       among other things, turnover and the 
                                     11

       
       recovery of payments (plus  accrued  interest)  made by the DPW, to
       the Hospital Providers in  the  amount  of  $13 million and the PCP
       Class  in  the  amount  of  $2.1  million  (collectively,  the "DPW
       Payments"),  after  confirmation  of  the  Plan,  as  unlawful Plan
       distributions and post-petition transfers.  (Maxicare Health Plans,
       Inc. and Penn Health  Corporation  v.  Albert Einstein et al. (Case
       No. AD96-01611));   (Maxicare  Health  Plans,  Inc. and Penn Health
       Corporation v. Faezeh  Behjat  et  al.  (Case No. AD96-01668)). The
       Company believes that  its  claims  against  the  defendants in the
       Provider  Bankruptcy  Actions  are  meritorious  and  that  it will
       prevail in  these  actions.    Notwithstanding  the  foregoing, the
       Company believes that its aggregate  recovery from the Board Action
       and the Provider Bankruptcy  Actions  will not exceed the aggregate
       amount of damages plus  accrued  interest  sought by Penn Health in
       the Board Action.

       b.  OTHER LITIGATION

       The Company is a defendant in a number of other lawsuits arising in
       the ordinary course  from  the  operations  of  its HMOs, including
       cases in which the plaintiffs  assert claims against the Company or
       third parties that  might  assert  indemnity or contribution claims
       against the Company for  malpractice,  negligence, bad faith in the
       failure to pay claims on a  timely basis or denial of coverage. The
       Company does not believe that  an  adverse determination in any one
       or more of these cases would have a material, adverse effect on the
       Company's business and operations.


       Item 2:  Change in Securities
                --------------------

                None.

       Item 3:  Defaults Upon Senior Securities
                -------------------------------

                None.

       Item 4:  Submission of Matters to a Vote of Security Holders
                ---------------------------------------------------

                None.

       Item 5:  Other Information
                -----------------

                None.








                                     12
       
       Item 6:  Exhibits and Reports on Form 8-K
                --------------------------------

                (a)  Exhibits
                     --------

                     Exhibit 10.3d.  Amended and Restated Employment and
                     Indemnification Agreement by and between Maxicare
                     Health Plans, Inc. and Peter J. Ratican, dated as of
                     April 1, 1996

                     Exhibit 10.4d.  Amended and Restated Employment and
                     Indemnification Agreement by and between Maxicare
                     Health Plans, Inc. and Eugene L. Froelich, dated as
                     of April 1, 1996


                     Exhibit 10.14a  Amendment No. 1 to the Stock Option
                     Agreement by and between Maxicare Health
                     Plans, Inc. and Peter J. Ratican, dated
                     as of December 5, 1990.

                     Exhibit 10.15a  Amendment No. 1 to the Stock Option
                     Agreement by and between Maxicare Health
                     Plans, Inc. and Eugene L. Froelich, dated
                     as of December 5, 1990.

                     Exhibit 10.42a  Amendment No. 1 to the Stock Option
                     Agreement by and between Maxicare Health
                     Plans, Inc. and Peter J. Ratican, dated
                     as of February 25, 1992.

                     Exhibit 10.43a  Amendment No. 1 to the Stock Option
                     Agreement by and between Maxicare Health
                     Plans, Inc. and Eugene L. Froelich, dated
                     as of February 25, 1992.


                     Exhibit 10.82a. Stock Option Agreement by and between
                     Maxicare Health Plans, Inc. and Peter J. Ratican,
                     dated as of April 1, 1996

                     Exhibit 10.82b. Stock Option Agreement by and between
                     Maxicare Health Plans, Inc. and Eugene L. Froelich,
                     dated as of April 1, 1996

                     Exhibit 27.  Financial Data Schedule

                (b)  Reports on Form 8-K
                     -------------------

                     None.




                                     13
       



                                   SIGNATURES



       Pursuant to the  requirements  of  the  Securities  Exchange Act of
       1934, the Registrant has duly  caused  this  report to be signed on
       its behalf by the undersigned thereunto duly authorized.



                                      MAXICARE HEALTH PLANS, INC.
                                      ---------------------------
                                            (Registrant)


       August 12, 1996                /s/ Eugene L. Froelich
                                      ---------------------------
                                          Eugene L. Froelich
                                      Chief Financial Officer and
                                      Executive Vice President -
                                      Finance and Administration

































                                     14
       
                                 INDEX TO EXHIBITS



       Exhibit                                                 Sequential
       Number    Description                                   Page Number
       ------    -----------------------------------------     -----------
       10.3d     Amended and Restated Employment and            16 of 119
                 Indemnification Agreement by and between
                 Maxicare Health Plans, Inc. and Peter J.
                 Ratican, dated as of April 1, 1996

       10.4d     Amended and Restated Employment and            51 of 119
                 Indemnification Agreement by and between
                 Maxicare Health Plans, Inc. and Eugene L.
                 Froelich, dated as of April 1, 1996

       10.14a    Amendment No. 1 to the Stock Option            86 of 119
                 Agreement by and between Maxicare Health
                 Plans, Inc. and Peter J. Ratican, dated
                 as of December 5, 1990

       10.15a    Amendment No. 1 to the Stock Option            90 of 119
                 Agreement by and between Maxicare Health
                 Plans, Inc. and Eugene L. Froelich, dated
                 as of December 5, 1990

       10.42a    Amendment No. 1 to the Stock Option            94 of 119
                 Agreement by and between Maxicare Health
                 Plans, Inc. and Peter J. Ratican, dated
                 as of February 25, 1992

       10.43a    Amendment No. 1 to the Stock Option            97 of 119
                 Agreement by and between Maxicare Health
                 Plans, Inc. and Eugene L. Froelich, dated
                 as of February 25, 1992

       10.82a    Stock Option Agreement by and between          100 of 119
                 Maxicare Health Plans, Inc. and Peter J.
                 Ratican, dated as of April 1, 1996

       10.82b    Stock Option Agreement by and between          109 of 119
                 Maxicare Health Plans, Inc. and Eugene L.
                 Froelich, dated as of April 1, 1996

       27        Financial Data Schedule                        118 of 119










                                     15